Title: Occupational Exposure to Tuberculosis TB
1Occupational Exposure to Tuberculosis (TB)
- John Furman
- Division of Occupational Safety Health
-
-
2Purpose of the Presentation
- Discuss DOSHs current enforcement procedures for
workplace exposure to tuberculosis (TB). - Discuss the new CDC guidelines for preventing
transmission of TB in healthcare (published
December 30, 2005) - Understand the implications to investigations of
healthcare facilities
3DOSH Enforcement
- No OSHA/DOSH TB control rule
- WRD 11.35 establishes enforcement of CDC TB
control guidelines - Safe workplace standard
- Hazard specific requirements
- OSHA enforcement directive CPL 2.106
- Currently enforcing 1994 CDC guidelines
- 2005 guidelines may be implemented without
penalty
4 Why did CDC revise TB guidelines?
- 1994 guidelines widely implemented in health-care
facilities - Advisory Council for the Elimination of
Tuberculosis (ACET) requested revision of 1994
guidelines based on decrease in TB incidence
rates - New Guidelines for Preventing the Transmission of
Mycobacterium tuberculosis in Health-Care
Settings, MMWR Vol. 54/No. RR-17 - Published December 30, 2005
5Why does OSHA/DOSH need to remain involved?
- TB remains a public health concern
- Infection rates greater than US average in
certain high risk populations - MDR-TB a growing concern
- HCWs face increased exposure risks
- 10 HCWs diagnosed with TB disease in 2005
- Recent cases of HCWs as exposure sources
6WRD 11.35
- Enforcement Procedures and Scheduling for
Occupational Exposure to Tuberculosis, OSHA
Instruction CPL 2.106, issued 1996 - References CDCs Guidelines for Preventing the
Transmission of tuberculosis in Health-Care
Facilities MMWR Vol. 43/No. RR-13, 1994 - Provides uniform inspection procedures
7WRD 11.35, Applicability
- Scope of workplaces
- Health Care Facilities
- Correctional Institutions
- Long-term Care Facilities for Elderly
- Homeless Shelters
- Drug Treatment Centers
8Incidence of TB
- 2005 TB rates
- US average rate was 4.9/100,000
- Washington rate 4.0/100,000
- cases TB disease holding steady at 253/yr
- King (127), Pierce (27), Snohomish (24) with
most cases - 3 cases of MDR-TB reported
9Risk Factors
- Foreign born
- Unemployed
- Homeless
- Excess alcohol
- HIV-AIDS positive
- Injecting drug use
- Other drug use
- Health care worker
- Previous diagnosis
- Resident of correctional facility
- Resident of long-term care facility
- Migrant worker
10HCW
- All paid and unpaid persons working in health
care settings - WISHAct applies only to the employer, employee
relationship - DOH, JCAHO, CMS et al expect that all HCWs are
included in the TB medical surveillance program
112005 GuidelinesSummary of Changes
- The scope of settings in which the guidelines
apply has been broadened to include laboratories
and additional outpatient and nontraditional
facility based settings. - These recommendations generally apply to an
entire health-care setting rather than areas
within a setting. - The risk assessment process includes the
assessment of additional aspects of infection
control
12Summary of Changes
- A written TB control plan is required
- Blood assay for M. tb, QuantiFERONTB Gold, may
be used instead of TST in TB screening programs
for HCWs. - Criteria for serial screening of HCWs are more
clearly defined. This may decrease the number of
HCWs who need serial TB screening. -
13Summary of Changes
- New terms, airborne infection precautions,
airborne infection isolation room (AII room),
tuberculin skin testing (TST), are introduced. - Information on ultraviolet germicidal irradiation
(UVGI) and room-air recirculation units has been
expanded. - AFB specimens may be taken 8-24 hours apart with
one being an early morning specimen.
14Summary of Changes
- Training recommendations have been expanded
- Competency of those administering and reading
TSTs - Recommendations for annual respirator training,
initial respirator fit testing, and periodic
respirator fit testing have been added. - The evidence of the need for respirator fit
testing is summarized.
15Expanded Scope
- New Terminology Health-care-associated settings
- used to broaden the potential places where
guidelines apply - Inpatient settings
- Patient rooms
- Emergency depts.
- Intensive care units
- Surgical suites
- Laboratories Lab procedure areas
- Bronchoscopy suites
- Sputum induction or inhalation therapy rooms
- Autopsy suites
- Embalming rooms
16Scope (cont.)
- Outpatient settings
- TB treatment facilities
- Medical offices
- Ambulatory-care settings
- Dialysis units
- Dental care settings
- Non-Traditional facility-based settings
- Emergency Medical Services (EMS)
- Long term care settings (hospices skilled
nursing facilities) - Settings in Correctional facilities (prisons,
jails, detention centers) - Home-based healthcare outreach settings
- Homeless shelters
17New TB Screening Blood Test
- D) QFT-G Blood test
- QuantiFERONTB Gold test (QFT-G) (Cellestis
Limited, Carnegie, Victoria, Australia) - A blood assay for M. tuberculosis (BAMT).
- Whole-blood interferon gamma release assay (IGRA)
- Might be used instead of TST in TB screening
programs for HCWs
18QFT vs. TST
- Pros of using QFT-G (BAMT)
- Cost effective alternative
- Only 1 visit for blood draw
- Results can be available in lt24 hours after
testing - Greater specificity for M. tuberculosis with BAMT
- Antigens used are not present in most NTM or
used for BCG - Can be used to screen persons vaccinated with BCG
- Not subject to boosting effect
- Not subject to placement and reading errors
- Cons of using QFT-G (BAMT)
- Possible errors in collecting or transporting
blood specimens - Incubation must be done w/in 16 hours of
collection - Lab-based errors in running or interpreting the
assay - Cost prohibitive?
19Appendix B TB Risk Assessment Worksheet
- Elements considered in Risk Assessment Process
- Incidence of TB (community facility)
- Risk Classification
- Screening of HCWs for M. TB infection
- TB Infection-Control Program
- Implementation of TB infection control plan based
on review by infection control committee - Lab processing of TB related specimens, tests,
results based on laboratory - Environmental controls
- Respiratory Protection Program
- Reassessment of TB Risks
20Risk Classification
Potential ongoing transmission Evidence of ongoi
ng transmission regardless of setting
- Low
- lt200 beds
- lt3 pts/yr
- gt200 beds
- lt6 pts/ yr
- Outpatient, nontraditional facility-based
- lt3pts/yr
- Medium
- lt200 beds
- gt3 pts/yr
- gt200 beds
- gt6 pts/ yr
- Outpatient, nontraditional facility-based
- gt3 pts/yr
21New Screening Frequency Recommendation
- Risk TB Screening Frequency
- Classification
- Low Baseline, further screening
-
is not necessary unless -
unless exposure - Medium Baseline, annual
screening - Potential Baseline, every
screening - ongoing
every 8-10 weeks - transmission
22Special Notes on Risk Classifications
- Classification of medium risk might need to be
assigned, even if a facility meets the low-risk
criteria when - Settings serve communities w/ high incidence of
TB disease - Settings that treat populations at high risk
(e.g., HIV patients) - Settings that treat patients w/ drug-resistant TB
disease - A classification of potential ongoing
transmission should be applied to a specific
group of HCWs or to a specific area of the
health-care setting in which evidence of ongoing
transmission is apparent, if such a group or area
can be identified. - Conduct investigation (screen workers every 8-10
wks until corrected) - Classification should be temporary
- The setting should be reclassified as medium risk
and recommended screening should be annual.
23Criteria for HCW screening
- All HCWs who share the air must be included
in the medical surveillance program. - HCWs whose duties do not include contact with
patients or TB specimens may not need to be
included in the serial TB screening program - In certain settings, this change will decrease
the number of HCWs who need serial TB screening
24TST/BAMT Positive HCWs
- Remote infection
- Initial and annual symptom screen
- Additional evaluations as indicated
- Education re symptoms and duty to report
- Baseline positive or conversion
- Symptom screen and CXR
- Additional evaluations as indicated
- Consider prophylaxis
25Airborne Infection Isolation (AII Room)
- New Terminology AII Room
- Airborne infection isolation room (AII room) is
introduced instead of the term negative pressure
room or AFB Isolation room - Another term used
- Airborne infection precautions - used instead of
airborne precautions
26AII Room (cont.)
- Use of other national consensus guidelines AIA,
ASHRAE - 6 ACH (existing) 12 ACH (new)
- Minimum of 2 ACH of outdoor air
- Monitoring devices
- Differential air flow rates and leakage
- Pressure differential from 0.001 to 0.01 in water
- Maintenance schedules
27Information on UVGI
- Information on ultraviolet germicidal irradiation
(UVGI) and room-air recirculation units has been
expanded. - Information on effectiveness of UVGI added
- Discussion of studies conducted which examine
- Air mixing
- Relative humidity
- Ventilation rates
28 Respiratory Protection
- Expanded section on respiratory protection
- Reference to OSHA Respiratory protection standard
requirement for Respiratory protection program - Selection criteria CDC/NIOSH approved
respirator - Medical screening/evaluation of those assigned
respirators - Annual training recommended
29Respiratory Protection
- WAC 296-842 applies to all respirator use at
work. - OSHA not enforcing annual fit test requirements
- DOSH will enforce 296-842 using state funds only
30(No Transcript)
31(No Transcript)
32(No Transcript)
33(No Transcript)
34(No Transcript)
35DOSH Inspection Focus
- Assignment of responsibility
- Written TB control plan
- TB risk assessment
- Medical surveillance
- Early detection and isolation
- Engineering controls
- Respiratory protection
- HCW training and education
- Respiratory etiquette
- Coordination with local health department
36Current Enforcement
- OSHA currently working on update to PCPL 2.106
- Formally still enforcing 1994 CDC guidelines
- Consult with DOSH ONC re facilities who have
implemented 2005 guidelines - Enforce DOSH Respirator rule re bio-agents
37